Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jan
9
2018
Prosecution History Informs Claim Meaning Even Without Unmistakable Disclaimer Foley & Lardner LLP
Aug
18
2022
Using Upfront IP Licensing to Reduce Future Supply Chain Disruptions Foley & Lardner LLP
Jan
23
2018
Three Things To Know About Rule 130 Declarations Foley & Lardner LLP
Sep
14
2022
Exception to the Rule? Late Submission of Evidence as Supplemental Information Under 37 C.F.R. 42.123(b) Foley & Lardner LLP
Feb
20
2018
Are These INOMax Therapeutic Method Claims Directed To A Natural Phenomenon? Foley & Lardner LLP
Oct
20
2022
Common Diligence Issues for Startup and Emerging Technology Companies Foley & Lardner LLP
Apr
16
2018
Federal Circuit Upholds Vanda Fanapt Personalized Method Claims Against Patent Eligibility Challenge Foley & Lardner LLP
May
15
2018
Claim Construction Of An Enantiomeric Chemical Structure Foley & Lardner LLP
Feb
27
2023
USPTO Launches Cancer Moonshot Expedited Examination Pilot Program Foley & Lardner LLP
Nov
16
2015
Federal Circuit To Revisit On Sale Bar Triggered By Contract Manufacture Foley & Lardner LLP
Jul
10
2018
Federal Circuit Upholds Zomig Patents Finding Intranasal Delivery Not Obviousness Foley & Lardner LLP
Jul
21
2018
Federal Circuit Affirms PTAB Ruling That Tribal Immunity Does Not Apply To IPRs Foley & Lardner LLP
Dec
17
2015
Federal Circuit Affirms PTAB's IPR Decision Invalidating A Pharmaceutical Patent Foley & Lardner LLP
Dec
30
2015
Use of Priority Denial to Subject Apparent "Pre-AIA" Patents to PGR: Inguran v. Premium Genetics Foley & Lardner LLP
Nov
14
2018
One-Year Time Bar for IPR Filing Triggered Even When Served Complaint Is Voluntarily Dismissed Foley & Lardner LLP
Jan
19
2016
PTAB Denies Challenge Of Abbvie Humira Patents Foley & Lardner LLP
Jan
29
2016
Split Federal Circuit Upholds Constitutionality of Single PTAB Panels Rendering Both Institution & Final Written Decisions Foley & Lardner LLP
Feb
11
2016
FDA Panel Shows Strong Support for Remicade Biosimilar Foley & Lardner LLP
Mar
15
2016
PTAB Institutes Kyle Bass IPR Against Pharmaceutical Patent Based On SEC Document Foley & Lardner LLP
May
20
2019
Federal Circuit Invalidates Patented Cancer Therapy Foley & Lardner LLP
Nov
27
2023
FTC Weighs in on Threats to Competition from Artificial Intelligence in Comment to U.S. Copyright Office Foley & Lardner LLP
Jan
3
2024
Startup Advisors: What is SAFE? [VIDEO] Foley & Lardner LLP
Aug
13
2019
Federal Circuit Agrees Genotyping Method Is Not Eligible For Patenting Foley & Lardner LLP
May
7
2016
USPTO Releases Patent Eligibility Update Foley & Lardner LLP
Feb
29
2024
Generative AI Systems Tee Up Fair Use Fight Foley & Lardner LLP
Jun
13
2016
PTAB Holds Technical Difficulties Will Not Save Late-Filed IPR Petitions Foley & Lardner LLP
Feb
12
2020
Automotive & Manufacturing MarketTrends | February 2020, Issue 4 Foley & Lardner LLP
Feb
18
2020
Trade Secret Ruling Is a Head Scratcher Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins